Carsten Fisher, MS

Behavioral Specialist

Carsten Fisher obtained his Master’s of Science degree in Behavioral Psychology from Pepperdine University in Malibu, California, where he graduated with honors. He specialized Applied Behavior Analysis and received clinical training in multiple settings with children and adults. He is currently working toward certification as a Board Certified Behavior Analyst, under the supervision of Clinton Fuller, MS, Licensed Behavior Analyst at the New England Center for OCD and Anxiety. He uses Exposure and Response Prevention (ERP) to treat OCD, and he has also received training in Acceptance and Commitment Therapy (ACT).

Compassionate Care for Kids with Autism

Prior to his move to New England, Carsten was a Program Manager at Behavior Trend Inc., where he supervised four Registered Behavior Technicians providing early-intervention therapy to individuals with Autism Spectrum Disorder and related disorders. He engaged in multidisciplinary collaborations for client curriculum development and treatment implementation, independent implementation of behavioral assessment tools, report writing for insurance providers, and support for client families. He led and co-created behavior-based training protocols for new hires in the workplace, and streamlined staff training processes. He also worked as a Registered Behavior Technician at FirstSteps for Kids, providing direct, early intervention behavior therapy for 6-8 clients diagnosed with Autism Spectrum Disorder and related disorders.

Healing from Oppression

Carsten's father was an anti-apartheid activitst in South Africa, and as such he has a deep understanding and appreciation for the impact of transgenerational trauma. He works with people suffering from the effects of racial trama and traumatization from multiple experiences of oppression.

Carsten is currently engaged in a graduate program through the Panthera Foundation where he is receiving advanced education in Psychedelic Therapy Training. Carsten feels strongly that these medicines need to be available to all in need of them, BIPOC and LGBTQ+ individuals especially.